The ESMO Preceptorship on Gastric Cancer 2025: Singapore is an intensive two-day educational event focused on the multidisciplinary management of gastric and gastro-esophageal junction (GEJ) cancers.

Scheduled for December 3–4, 2025, in Singapore, Republic of Singapore, the program is designed to cover topics ranging from the fundamentals of epidemiology and molecular factors to best clinical practices in surgical, adjuvant, and metastatic settings. The course aims to teach participants to compare various approaches, manage special situations and side effects, and learn about novel treatment targets. This event is accredited with 9 ESMO-MORA category 1 points.